Circulating MicroRNAs in Plasma of Hepatitis B e Antigen Positive Children Reveal Liver-Specific Target Genes

Background and Aim. Hepatitis B e antigen positive (HBeAg-positive) children are at high risk of severe complications such as hepatocellular carcinoma and cirrhosis. Liver damage is caused by the host immune response to infected hepatocytes, and we hypothesise that specific microRNAs play a role in this complex interaction between virus and host. The study aimed to identify microRNAs with aberrant plasma expressions in HBeAg-positive children and with liver-specific target genes. Methods. By revisiting our previous screen of microRNA plasma levels in HBeAg-positive and HBeAg-negative children with chronic hepatitis B (CHB) and in healthy controls, candidate microRNAs with aberrant plasma expressions in HBeAg-positive children were identified. MicroRNAs targeting liver-specific genes were selected based on bioinformatics analysis and validated by qRT-PCR using plasma samples from 34 HBeAg-positive, 26 HBeAg-negative, and 60 healthy control children. Results. Thirteen microRNAs showed aberrant plasma expressions in HBeAg-positive children and targeted liver-specific genes. In particular, three microRNAs were upregulated and one was downregulated in HBeAg-positive children compared to HBeAg-negative and healthy control children, which showed equal levels. Conclusion. The identified microRNAs might impact the progression of CHB in children. Functional studies are warranted, however, to elucidate the microRNAs' role in the immunopathogenesis of childhood CHB.

[1]  A. Patel,et al.  MAZ, a zinc finger protein, binds to c-MYC and C2 gene sequences regulating transcriptional initiation and termination. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[2]  C. J. Chen,et al.  Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives. , 2000, Journal of the National Cancer Institute.

[3]  S. Thorgeirsson,et al.  Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis , 2000, Oncogene.

[4]  K. Furuyama,et al.  Expression of coproporphyrinogen oxidase and synthesis of hemoglobin in human erythroleukemia K562 cells. , 2001, European journal of biochemistry.

[5]  M. Katoh,et al.  Molecular cloning and characterization of FRAT2, encoding a positive regulator of the WNT signaling pathway. , 2001, Biochemical and biophysical research communications.

[6]  F. Speleman,et al.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.

[7]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[8]  B. McMahon,et al.  Chronic hepatitis B: Update of recommendations , 2004, Hepatology.

[9]  H. Will,et al.  The hepatitis B virus PRE contains a splicing regulatory element , 2006, Nucleic acids research.

[10]  S. Thorgeirsson,et al.  Oncogene‐specific gene expression signatures at preneoplastic stage in mice define distinct mechanisms of hepatocarcinogenesis , 2006, Hepatology.

[11]  E. Moran,et al.  The c-myc gene is a direct target of mammalian SWI/SNF-related complexes during differentiation-associated cell cycle arrest. , 2006, Cancer research.

[12]  A. Gatta,et al.  Chronic hepatitis B in children after e antigen seroclearance: Final report of a 29‐year longitudinal study , 2006, Hepatology.

[13]  Jiang Qian,et al.  TiGER: A database for tissue-specific gene expression and regulation , 2008, BMC Bioinformatics.

[14]  A. Giannattasio,et al.  Long-term outcome in children with chronic hepatitis B: a 24-year observation period. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  S. Shieh,et al.  The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1 , 2007, The EMBO journal.

[16]  C. Sander,et al.  A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing , 2007, Cell.

[17]  H. Hsu,et al.  Viremia profiles in children with chronic hepatitis B virus infection and spontaneous e antigen seroconversion. , 2007, Gastroenterology.

[18]  F. Haller,et al.  Altered regulation of Prox1-gene-expression in liver tumors , 2008, BMC Cancer.

[19]  Joan M. Block,et al.  Recommendations for Screening, Monitoring, and Referral of Pediatric Chronic Hepatitis B , 2009, Pediatrics.

[20]  Yi Tie,et al.  MicroRNA-193b regulates proliferation, migration and invasion in human hepatocellular carcinoma cells. , 2010, European journal of cancer.

[21]  Wenlin Huang,et al.  Cellular MicroRNAs Inhibit Replication of the H1N1 Influenza A Virus in Infected Cells , 2010, Journal of Virology.

[22]  N. Kiviat,et al.  DNA methylation changes in normal liver tissues and hepatocellular carcinoma with different viral infection. , 2010, Experimental and molecular pathology.

[23]  Chi Zhang,et al.  TiSGeD: a database for tissue-specific genes , 2010, Bioinform..

[24]  Ryan M. O’Connell,et al.  Physiological and pathological roles for microRNAs in the immune system , 2010, Nature Reviews Immunology.

[25]  Y. Doki,et al.  The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma. , 2010, Journal of hepatology.

[26]  Hui Zhou,et al.  starBase: a database for exploring microRNA–mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data , 2010, Nucleic Acids Res..

[27]  Peng-jun Zhang,et al.  Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies , 2010, Clinical science.

[28]  Paul J Rider,et al.  A liver‐specific microRNA binds to a highly conserved RNA sequence of hepatitis B virus and negatively regulates viral gene expression and replication , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  M. Zavolan,et al.  Analysis of in situ pre-mRNA targets of human splicing factor SF1 reveals a function in alternative splicing , 2010, Nucleic acids research.

[30]  T. Ishikawa,et al.  Enhanced expression of coproporphyrinogen oxidase in malignant brain tumors: CPOX expression and 5-ALA-induced fluorescence. , 2011, Neuro-oncology.

[31]  Q. Ye,et al.  Identification of Suitable Reference Genes for qRT-PCR Analysis of Circulating microRNAs in Hepatitis B Virus-Infected Patients , 2011, Molecular Biotechnology.

[32]  M. Esteller Non-coding RNAs in human disease , 2011, Nature Reviews Genetics.

[33]  R. Yang,et al.  Let-7c MicroRNA Expression and Clinical Significance in Hepatocellular Carcinoma , 2011, The Journal of international medical research.

[34]  EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. , 2012, Journal of hepatology.

[35]  Tao Huang,et al.  Differential combinatorial regulatory network analysis related to venous metastasis of hepatocellular carcinoma , 2012, BMC Genomics.

[36]  Keith A. Boroevich,et al.  Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators , 2012, Nature Genetics.

[37]  Lanjuan Li,et al.  Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year period. , 2012, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[38]  Boping Zhou,et al.  Exome sequencing of hepatitis B virus–associated hepatocellular carcinoma , 2012, Nature Genetics.

[39]  S. Dalton,et al.  Frat Is a Phosphatidylinositol 3-Kinase/Akt-Regulated Determinant of Glycogen Synthase Kinase 3β Subcellular Localization in Pluripotent Cells , 2012, Molecular and Cellular Biology.

[40]  X. Gu,et al.  microRNA expression profiles in human colorectal cancers with brain metastases. , 2012, Oncology letters.

[41]  Sukriti,et al.  Analysis of Notch and TGF-β Signaling Expression in Different Stages of Disease Progression During Hepatitis B Virus Infection , 2012, Clinical and Translational Gastroenterology.

[42]  Haoliang Zhao,et al.  MicroRNA-125b Functions as a Tumor Suppressor in Hepatocellular Carcinoma Cells , 2012, International journal of molecular sciences.

[43]  S. Imbeaud,et al.  Next-generation sequencing identified new oncogenes and tumor suppressor genes in human hepatic tumors , 2012, Oncoimmunology.

[44]  Y. Mao,et al.  Serum miR-18a: A Potential Marker for Hepatitis B Virus-Related Hepatocellular Carcinoma Screening , 2012, Digestive Diseases and Sciences.

[45]  L. Yao,et al.  Smad4 expression in hepatocellular carcinoma differs by hepatitis status. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[46]  F. Pociot,et al.  Differential Plasma MicroRNA Profiles in HBeAg Positive and HBeAg Negative Children with Chronic Hepatitis B , 2013, PloS one.

[47]  G. Yousef,et al.  Clinical evaluation of microRNA expression profiling in non small cell lung cancer. , 2013, Lung cancer.

[48]  G. Mieli-Vergani,et al.  Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines: consensus of an expert panel on behalf of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition. , 2013, Journal of hepatology.

[49]  F. Pociot,et al.  Hepatitis B Surface Antigen Quantity Positively Correlates with Plasma Levels of microRNAs Differentially Expressed in Immunological Phases of Chronic Hepatitis B in Children , 2013, PloS one.

[50]  S. Kauppinen,et al.  Treatment of HCV infection by targeting microRNA. , 2013, The New England journal of medicine.

[51]  P. Ye,et al.  MicroRNAs may solve the mystery of chronic hepatitis B virus infection. , 2013, World journal of gastroenterology.

[52]  Je-Yoel Cho,et al.  MicroRNA-365 regulates NKX2-1, a key mediator of lung cancer. , 2013, Cancer letters.

[53]  F. Shen,et al.  GATA6 predicts prognosis and hepatic metastasis of colorectal cancer. , 2013, Oncology reports.

[54]  C. Larsson,et al.  MicroRNA Expression Patterns Related to Merkel Cell Polyomavirus Infection in Human Merkel Cell Carcinoma , 2013, The Journal of investigative dermatology.

[55]  A. Levine,et al.  MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c, miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p, mapped to the 14q32.31 locus, regulate proliferation, apoptosis, migration and invasion in metastatic prostate cancer cells , 2014, Oncogene.